Fabian Leendertz is a German virologist specializing in emerging and re‑emerging viral diseases. He serves as the head of the Emerging Viral Diseases unit at the Robert Koch Institute (RKI) in Berlin, Germany, where he oversees research, surveillance, and response activities related to high‑consequence pathogens.
Education and Early Career
Leendertz earned his medical degree (MD) and a doctorate (Dr. med.) in virology from German institutions; specific details of his alma mater and dissertation topic are not publicly disclosed. Following his clinical training, he pursued post‑doctoral research focusing on zoonotic viral infections, particularly filoviruses such as Ebola and Marburg.
Research Focus
Leendertz’s work centers on the ecology, epidemiology, and pathogenesis of viral hemorrhagic fevers and other emerging infectious diseases. His research has addressed:
- The identification and characterization of novel filoviruses in wildlife reservoirs.
- Molecular and serological surveillance of Ebola, Marburg, Lassa, and other high‑risk viruses in both animal hosts and human populations.
- Development of diagnostic tools and protocols for rapid detection of emerging viruses.
- Evaluation of public‑health interventions and outbreak response strategies in collaboration with national and international health agencies.
Professional Roles and Contributions
- Head, Emerging Viral Diseases Unit, Robert Koch Institute (RKI) – Leads a multidisciplinary team that conducts laboratory diagnostics, field investigations, and risk assessments for viral threats.
- Member, WHO R&D Blueprint Expert Group – Contributes expertise to the World Health Organization’s agenda for accelerating research and development of medical countermeasures against priority pathogens.
- Scientific Advisory Board, European Centre for Disease Prevention and Control (ECDC) – Provides guidance on surveillance and preparedness for emerging viral diseases within the European Union.
Selected Publications
Leendertz has authored or co‑authored numerous peer‑reviewed articles in journals such as The Lancet Infectious Diseases, Journal of Virology, and Emerging Infectious Diseases. Representative works include:
- Leendertz, F. et al. (2016). “Discovery of novel Ebola virus–related filoviruses in bats in West Africa.” Nature Microbiology.
- Leendertz, F. et al. (2020). “Seroprevalence of Lassa virus in rodent reservoirs and implications for human spill‑over.” PLoS Neglected Tropical Diseases.
Recognition
Leendertz’s contributions to virology and public health have been acknowledged through research grants from the German Federal Ministry of Education and Research (BMBF) and collaborative projects funded by the European Union’s Horizon 2020 program.
Public Engagement
He frequently participates in scientific conferences, media briefings, and policy workshops to communicate risks associated with emerging viral pathogens and to promote evidence‑based preparedness measures.
Personal Information
Details such as his date of birth and early personal background are not publicly documented, consistent with standard privacy practices for researchers.